Our Leadership

Management Team

Executive Chairman

Wolfgang Daum, PhD

Managing Partner of Carlyle Global Advisors
Angel investor with Keiretsu Forum in Palo Alto, CA
Wolfgang is a serial entrepreneur who has helped build and successfully exited from many life science companies in the areas of medical diagnostics and medical devices for neurological disease, cardiovascular disease and oncology. He is passionate about turning great scientific science into commercial success.

Executive VP, Sales & Marketing

Krinx Kong, BBA

Krinx received his BBA in Marketing from the McCombs School of Business at the University of Texas, Austin.
His career began during his Senior year where he was hired by Merck & Co. For the following 22 years, he’s been delivering results with leadership roles in commercial healthcare sales, marketing and business development, primarily in the areas of cardiovascular disease, oncology and clinical wellness.
His broad range of experience in the healthcare sector from early stage start-ups to fortune 500 companies in the pharma, hospital and laboratory diagnostic space sets him apart.

CFO

Anna Lau, MBA, CPA (inactive, FL)

Angel investor with Portfolia and Berkeley Angel Network
UNC-Chapel Hill MBA in Strategy & Marketing, BS Accounting, BS Finance, former CPA
Anna’s experience in accounting, finance, sales and HR spans from Fortune 100 multinational companies to health tech startups.

Director of Translational Science

Zuzana Krejciova-Rajaniemi, PhD

Zuzana received her PhD from the University of Edinburgh, UK, where she used human stem cell derived models to study mechanisms of neurodegeneration. She then joined Nobel Laureate Stanley Prusiner’s lab at UCSF as a postdoc and worked on developing in vitro and in vivo models of neurodegenerative diseases. Having gone through a personal journey with inflammation, she is passionate about uncovering the underlying mechanisms of chronic illness and aging.

Board of Directors

Executive Chairman

Wolfgang Daum, PhD

Managing Partner of Carlyle Global Advisors
Angel investor with Keiretsu Forum in Palo Alto, CA
Wolfgang is a serial entrepreneur who has helped build and successfully exited from many life science companies in the areas of medical diagnostics and medical devices for neurological disease, cardiovascular disease and oncology. He is passionate about turning great scientific science into commercial success.

Founder and Chief Scientific Officer

David Furman, PhD

Director, Stanford 1000 Immunomes Project
Principal Investigator, National Scientific Research Council, Argentina

Artificial Intelligence in Biomarker Discovery

Board Member and Scientific Advisor

Eric Verdin, MD

President & CEO, Buck Institute for Research on Aging
Leading Scientist in the Field of Inflammation and Aging

Scientific Advisors

Scientific Co-founder

Mark M. Davis, PhD

Director, Stanford Institute for Immunity, Transplantation and Infection
Professor of Immunology, Stanford School of Medicine

Molecular Immunology and Systems Immunology

Founder and Chief Scientific Officer

David Furman, PhD

Director, Stanford 1000 Immunomes Project
Principal Investigator, National Scientific Research Council, Argentina

Artificial Intelligence in Biomarker Discovery

Scientific Advisor

Joeseph Wu, MD, PhD

Director, Stanford Cardiovascular Institute
Simon H. Stertzer Endowed Professor in Department of Medicine (Cardiology) and Department of Radiology, Stanford School of Medicine